Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India
Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India
复制标题
伊马替尼时代 Sokal、Euro 和 EUTOS 评分对慢性粒细胞白血病的预后和预测意义——来自印度南部三级肿瘤中心的经验
作者：
L. Kuntegowdanahalli;G. Kanakasetty;Aditi Harsh Thanky;L. Dasappa;L. Jacob;S. Mallekavu;R. Lakkavalli;L. Kadabur;R. Haleshappa
慢性粒细胞白血病（CML）是一种骨髓增生性疾病。多年来，已经开发了许多预后模型，以更好地在基线对这种疾病进行风险分层。索卡尔、Euro和EUTOS评分在最初接受各种治疗的不同人群中进行。在这里，我们试图确定他们的预测和预后的影响，在一个更大的人口与CML-CP（慢性期）的印度患者在伊马替尼时代。
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder. Over the years many prognostic models have been developed to better risk stratify this disease at baseline. Sokal, Euro, and EUTOS scores were developed in varied populations initially receiving various therapies. Here we try to identify their predictive and prognostic implication in a larger population of Indian patients with CML-CP (chronic phase) in the imatinib era.
慢性粒细胞白血病：患者特征和治疗与生存之间关系的多变量分析。
影响因子：
20.3
作者：
Kantarjian,HM;Smith,TL;McCredie,KB;Keating,MJ;Walters,RS;Talpaz,M;Hester,JP;Bligham,G;Gehan,E;Freireich,EJ
通讯作者：
Freireich,EJ
影响因子：
20.3
作者：
Jabbour, Elias;Cortes, Jorge;Kantarjian, Hagop
通讯作者：
Kantarjian, Hagop